Free Trial

CoreWeave (CRWV) Financials

CoreWeave logo
$117.03 +10.32 (+9.67%)
Closing price 04:00 PM Eastern
Extended Trading
$117.42 +0.39 (+0.34%)
As of 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for CoreWeave

Annual Income Statements for CoreWeave

This table shows CoreWeave's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2023 2024 2025
Period end date 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
-594 -937 -1,196
Consolidated Net Income / (Loss)
-594 -863 -1,167
Net Income / (Loss) Continuing Operations
-594 -863 -1,167
Total Pre-Tax Income
-558 -744 -1,215
Total Operating Income
-14 324 -46
Total Gross Profit
160 1,422 3,678
Total Revenue
229 1,915 5,131
Operating Revenue
229 1,915 5,131
Total Cost of Revenue
69 493 1,453
Operating Cost of Revenue
69 493 1,453
Total Operating Expenses
174 1,098 3,724
Selling, General & Admin Expense
30 119 651
Marketing Expense
13 18 144
Other Operating Expenses / (Income)
131 961 2,929
Total Other Income / (Expense), net
-544 -1,068 -1,169
Interest & Investment Income
-28 -361 -1,229
Other Income / (Expense), net
-516 -707 60
Income Tax Expense
36 119 -48
Basic Earnings per Share
($3.09) ($4.30) ($2.75)
Weighted Average Basic Shares Outstanding
192M 218M 435M
Diluted Earnings per Share
($3.09) ($4.30) ($2.81)
Weighted Average Diluted Shares Outstanding
192M 218M 436M
Weighted Average Basic & Diluted Shares Outstanding
- - 525.69M
Cash Dividends to Common per Share
- $0.00 $0.00

Quarterly Income Statements for CoreWeave

This table shows CoreWeave's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Income / (Loss) Attributable to Common Shareholders
-129 -339 -389 -80 -343 -291 -110 -452 -740
Consolidated Net Income / (Loss)
-129 -323 -360 -51 -315 -291 -110 -452 -740
Net Income / (Loss) Continuing Operations
-129 -323 -360 -51 -315 -291 -110 -452 -740
Total Pre-Tax Income
-114 -283 -318 -29 -269 -243 -237 -467 -656
Total Operating Income
17 78 117 112 -27 19 52 -90 -144
Total Gross Profit
129 287 441 565 720 900 996 1,063 1,362
Total Revenue
189 395 584 747 982 1,213 1,365 1,572 2,078
Operating Revenue
189 395 584 747 982 1,213 1,365 1,572 2,078
Total Cost of Revenue
59 109 143 182 262 313 369 509 716
Operating Cost of Revenue
59 109 143 182 262 313 369 509 716
Total Operating Expenses
113 209 324 453 747 881 944 1,152 1,506
Selling, General & Admin Expense
16 22 34 48 175 174 152 150 164
Marketing Expense
4.05 4.17 4.55 5.22 11 37 45 52 69
Other Operating Expenses / (Income)
93 183 286 400 561 670 747 950 1,273
Total Other Income / (Expense), net
-131 -361 -435 -141 -242 -262 -289 -377 -512
Interest & Investment Income
-41 -67 -104 -149 -264 -267 -311 -388 -536
Other Income / (Expense), net
-90 -294 -331 7.75 22 5.02 22 10 24
Income Tax Expense
15 40 42 22 46 48 -127 -15 84
Basic Earnings per Share
($0.62) ($1.62) ($1.82) ($0.24) ($1.40) ($0.60) ($0.22) ($0.53) ($1.40)
Weighted Average Basic Shares Outstanding
209.23M 209.63M 213.81M 218M 246M 486.59M 497.89M 435M 527M
Diluted Earnings per Share
($0.62) ($1.62) ($1.82) ($0.24) ($1.49) ($0.60) ($0.22) ($0.50) ($1.40)
Weighted Average Diluted Shares Outstanding
209.23M 209.63M 213.81M 218M 249M 486.59M 497.89M 436M 527M
Weighted Average Basic & Diluted Shares Outstanding
- - - 0.00 479.98M 488.57M 498.32M 525.69M 545.57M
Cash Dividends to Common per Share
- - - - $0.00 - - - $0.00

Annual Cash Flow Statements for CoreWeave

This table details how cash moves in and out of CoreWeave's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2023 2024 2025
Period end date 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
473 1,555 2,095
Net Cash From Operating Activities
1,833 2,749 3,058
Net Cash From Continuing Operating Activities
1,833 2,749 3,058
Net Income / (Loss) Continuing Operations
-594 -863 -1,167
Consolidated Net Income / (Loss)
-594 -863 -1,167
Depreciation Expense
103 863 2,454
Amortization Expense
16 33 110
Non-Cash Adjustments To Reconcile Net Income
569 922 979
Changes in Operating Assets and Liabilities, net
1,739 1,794 682
Net Cash From Investing Activities
-3,148 -8,658 -10,271
Net Cash From Continuing Investing Activities
-3,148 -8,658 -10,271
Purchase of Property, Plant & Equipment
-2,943 -8,702 -10,309
Acquisitions
0.00 0.00 -108
Purchase of Investments
-172 -34 -47
Sale and/or Maturity of Investments
6.00 188 43
Other Investing Activities, net
-39 -110 150
Net Cash From Financing Activities
1,788 7,464 9,308
Net Cash From Continuing Financing Activities
1,788 7,464 9,308
Repayment of Debt
-54 -671 -3,519
Payment of Dividends
0.00 -58 -29
Issuance of Debt
1,404 7,018 11,829
Issuance of Preferred Equity
421 1,172 0.00
Issuance of Common Equity
15 0.00 1,491
Other Financing Activities, net
2.00 3.00 -464
Cash Interest Paid
0.00 184 869

Quarterly Cash Flow Statements for CoreWeave

This table details how cash moves in and out of CoreWeave's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Change in Cash & Equivalents
1,187 -427 682 113 482 -464 915 1,162 -810
Net Cash From Operating Activities
2,039 -118 641 187 61 -251 1,689 1,559 2,984
Net Cash From Continuing Operating Activities
2,039 -118 641 187 61 -251 1,689 1,559 2,984
Net Income / (Loss) Continuing Operations
-129 -323 -360 -51 -315 -291 -110 -452 -740
Consolidated Net Income / (Loss)
-129 -323 -360 -51 -315 -291 -110 -452 -740
Depreciation Expense
80 164 254 365 443 559 630 821 1,147
Amortization Expense
8.06 7.55 7.40 10.00 38 29 21 22 208
Non-Cash Adjustments To Reconcile Net Income
115 351 398 58 224 273 249 284 232
Changes in Operating Assets and Liabilities, net
1,966 -317 342 -196 -329 -823 899 884 2,137
Net Cash From Investing Activities
-1,771 -2,250 -1,173 -3,464 -1,433 -2,442 -2,470 -3,926 -7,708
Net Cash From Continuing Investing Activities
-1,771 -2,250 -1,173 -3,464 -1,433 -2,442 -2,470 -3,926 -7,708
Purchase of Property, Plant & Equipment
-1,742 -2,247 -1,215 -3,498 -1,407 -2,453 -2,389 -4,060 -7,695
Sale and/or Maturity of Investments
0.00 49 47 92 29 - - 14 12
Other Investing Activities, net
- - - -109 -55 - -24 172 -25
Net Cash From Financing Activities
919 1,940 1,214 3,391 1,854 2,229 1,696 3,529 3,914
Net Cash From Continuing Financing Activities
919 1,940 1,214 3,391 1,854 2,229 1,696 3,529 3,914
Repayment of Debt
-37 -98 -264 -272 -312 -1,358 -1,434 -429 -1,361
Payment of Dividends
0.00 - -29 -29 -26 -2.59 - -0.31 0.00
Issuance of Debt
932 890 1,508 3,689 785 3,648 3,130 4,266 3,290
Issuance of Common Equity
0.00 - - - 1,423 68 - 0.71 1,985
Other Financing Activities, net
0.05 0.60 0.69 1.67 -16 -115 1.50 -337 0.00
Cash Interest Paid
1.97 23 73 87 142 219 196 312 364

Annual Balance Sheets for CoreWeave

This table presents CoreWeave's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2024 2025
Period end date 12/31/2024 12/31/2025
Total Assets
17,833 49,302
Total Current Assets
1,916 7,488
Cash & Equivalents
1,361 3,127
Restricted Cash
37 819
Short-Term Investments
0.00 34
Accounts Receivable
417 3,169
Prepaid Expenses
101 339
Plant, Property, & Equipment, net
11,915 30,557
Total Noncurrent Assets
4,002 11,257
Goodwill
20 1,101
Intangible Assets
5.00 235
Other Noncurrent Operating Assets
3,311 9,737
Other Noncurrent Nonoperating Assets
637 184
Total Liabilities & Shareholders' Equity
17,833 49,302
Total Liabilities
16,525 45,967
Total Current Liabilities
4,963 16,440
Short-Term Debt
2,468 6,708
Accounts Payable
868 1,623
Accrued Expenses
356 5,773
Current Deferred Revenue
769 1,709
Other Current Liabilities
502 627
Total Noncurrent Liabilities
11,562 29,527
Long-Term Debt
5,458 14,665
Noncurrent Deferred Revenue
3,295 6,476
Noncurrent Deferred & Payable Income Tax Liabilities
149 115
Other Noncurrent Operating Liabilities
2,660 8,271
Commitments & Contingencies
0.00 0.00
Total Equity & Noncontrolling Interests
-414 3,335
Total Preferred & Common Equity
-414 3,335
Preferred Stock
0.00 0.00
Total Common Equity
-414 3,335
Common Stock
1,096 6,012
Retained Earnings
-1,476 -2,643
Treasury Stock
-34 -34
Accumulated Other Comprehensive Income / (Loss)
- 0.00

Quarterly Balance Sheets for CoreWeave

This table presents CoreWeave's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2025 Q2 2025 Q3 2025 Q1 2026
Period end date 3/31/2025 6/30/2025 9/30/2025 3/31/2026
Total Assets
21,860 26,241 32,910 55,573
Total Current Assets
3,103 3,946 4,731 5,609
Cash & Equivalents
1,276 1,153 1,894 2,244
Restricted Cash
624 560 597 777
Short-Term Investments
- - 47 22
Accounts Receivable
1,055 1,934 1,659 2,120
Prepaid Expenses
147 299 533 446
Plant, Property, & Equipment, net
14,211 16,632 20,659 36,424
Total Noncurrent Assets
4,547 5,664 7,520 13,540
Goodwill
20 813 830 1,101
Intangible Assets
4.40 206 200 224
Other Noncurrent Operating Assets
3,906 4,304 6,013 11,916
Other Noncurrent Nonoperating Assets
617 341 478 299
Total Liabilities & Shareholders' Equity
21,860 26,241 32,910 55,573
Total Liabilities
18,791 22,421 29,032 50,814
Total Current Liabilities
7,131 7,556 9,715 17,818
Short-Term Debt
3,777 3,628 3,712 7,547
Accounts Payable
1,242 1,227 1,157 3,371
Accrued Expenses
1,377 1,411 3,172 2,726
Current Deferred Revenue
437 951 1,108 2,130
Other Current Liabilities
299 340 566 2,044
Total Noncurrent Liabilities
11,660 14,864 19,318 32,996
Long-Term Debt
4,935 7,424 10,323 17,312
Noncurrent Deferred Revenue
3,611 3,896 4,228 5,393
Noncurrent Deferred & Payable Income Tax Liabilities
194 246 118 194
Other Noncurrent Operating Liabilities
2,920 3,299 4,649 10,097
Commitments & Contingencies
0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
1,906 2,658 3,878 4,759
Total Preferred & Common Equity
1,906 2,658 3,878 4,759
Preferred Stock
0.00 0.00 0.00 0.00
Total Common Equity
1,906 2,658 3,878 4,759
Common Stock
3,731 4,773 6,104 8,171
Retained Earnings
-1,791 -2,081 -2,192 -3,383
Treasury Stock
-34 -34 -34 -34
Accumulated Other Comprehensive Income / (Loss)
- -0.27 -1.28 5.00

Annual Metrics And Ratios for CoreWeave

This table displays calculated financial ratios and metrics derived from CoreWeave's official financial filings.

Metric 2023 2024 2025
Period end date 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding
0.00 0.00 498,317,512.00
DEI Adjusted Shares Outstanding
0.00 0.00 498,317,512.00
DEI Earnings Per Adjusted Shares Outstanding
0.00 0.00 -2.40
Growth Metrics
- - -
Profitability Metrics
- - -
Net Operating Profit after Tax (NOPAT)
-9.80 227 -32
Return On Investment Capital (ROIC_SIMPLE)
- 3.02% -0.13%
Earnings before Interest and Taxes (EBIT)
-530 -383 14
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-411 513 2,578
Valuation Ratios
- - -
Leverage & Solvency
- - -
Liquidity Ratios
- - -
Cash Flow Metrics
- - -
Free Cash Flow to Firm (FCFF)
0.00 -6,943 -13,406
Efficiency Ratios
- - -
Capital & Investment Metrics
- - -
Invested Capital
0.00 7,170 20,544
Increase / (Decrease) in Invested Capital
0.00 7,170 13,374
Book Value per Share
$0.00 ($1.90) $6.69
Tangible Book Value per Share
$0.00 ($2.01) $4.01
Total Capital
0.00 9,234 24,708
Total Debt
0.00 7,926 21,373
Total Long-Term Debt
0.00 5,458 14,665
Net Debt
0.00 6,499 17,393
Capital Expenditures (CapEx)
2,943 8,702 10,309
Debt-free, Cash-free Net Working Capital (DFCFNWC)
0.00 -1,977 -6,224
Debt-free Net Working Capital (DFNWC)
0.00 -579 -2,244
Net Working Capital (NWC)
0.00 -3,047 -8,952
Net Nonoperating Expense (NNE)
584 1,090 1,135
Net Nonoperating Obligations (NNO)
0.00 5,862 17,209
Total Depreciation and Amortization (D&A)
119 896 2,564
Earnings Adjustments
- - -
Adjusted Basic Earnings per Share
$0.00 $0.00 ($2.75)
Adjusted Weighted Average Basic Shares Outstanding
0.00 0.00 435M
Adjusted Diluted Earnings per Share
$0.00 $0.00 ($2.81)
Adjusted Weighted Average Diluted Shares Outstanding
0.00 0.00 436M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 0.00 525.69M
Normalized Net Operating Profit after Tax (NOPAT)
-9.80 227 -32
Debt Service Ratios
- - -
Payout Ratios
- - -

Quarterly Metrics And Ratios for CoreWeave

This table displays calculated financial ratios and metrics derived from CoreWeave's official financial filings.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
DEI Shares Outstanding
- - - 0.00 - - - 498,317,512.00 525,688,133.00
DEI Adjusted Shares Outstanding
- - - 0.00 - - - 498,317,512.00 525,688,133.00
DEI Earnings Per Adjusted Shares Outstanding
- - - 0.00 - - - -0.91 -1.41
Growth Metrics
- - - - - - - - -
Revenue Growth
0.00% 0.00% 0.00% - 420.25% 206.75% 133.70% - 111.61%
EBITDA Growth
0.00% 0.00% 0.00% - 3,214.21% 1,489.55% 1,422.16% - 159.45%
EBIT Growth
0.00% 0.00% 0.00% - 93.48% 111.21% 134.50% - -2,300.00%
NOPAT Growth
0.00% 0.00% 0.00% - -263.06% -75.28% -55.73% - -433.33%
Net Income Growth
0.00% 0.00% 0.00% - -143.44% 10.07% 69.39% - -134.92%
EPS Growth
0.00% 0.00% 0.00% - -140.32% 62.96% 87.91% - 6.04%
Operating Cash Flow Growth
0.00% 0.00% 0.00% - -97.00% -113.24% 163.42% - 4,791.80%
Free Cash Flow Firm Growth
0.00% 0.00% 0.00% - 0.00% 0.00% 0.00% - -84.37%
Invested Capital Growth
0.00% 0.00% 0.00% - 0.00% 0.00% 0.00% - 183.66%
Revenue Q/Q Growth
0.00% 109.54% 47.69% - 0.00% 23.55% 12.52% - 32.20%
EBITDA Q/Q Growth
0.00% -406.76% 208.05% - 0.00% 28.62% 18.36% - 61.74%
EBIT Q/Q Growth
0.00% -195.25% 1.08% - 0.00% 608.01% 204.35% - -51.49%
NOPAT Q/Q Growth
0.00% 361.33% 50.69% - 0.00% 169.93% 169.93% - -60.73%
Net Income Q/Q Growth
0.00% -149.92% -11.39% - 0.00% 7.67% 62.09% - -63.82%
EPS Q/Q Growth
0.00% -161.29% -12.35% - 0.00% 59.73% 63.33% - -180.00%
Operating Cash Flow Q/Q Growth
0.00% -105.78% 644.22% - 0.00% -510.76% 772.29% - 91.41%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% 0.00% - 0.00% -37.95% -16.05% - -27.37%
Invested Capital Q/Q Growth
0.00% 0.00% 0.00% - 0.00% 38.38% 16.21% - 27.90%
Profitability Metrics
- - - - - - - - -
Gross Margin
68.61% 72.47% 75.49% - 73.27% 74.22% 72.97% - 65.54%
EBITDA Margin
7.62% -11.15% 8.16% - 48.53% 50.52% 53.15% - 59.43%
Operating Margin
8.93% 19.66% 20.06% - -2.80% 1.58% 3.80% - -6.93%
EBIT Margin
-38.79% -54.66% -36.61% - -0.49% 2.00% 5.40% - -5.77%
Profit (Net Income) Margin
-68.50% -81.70% -61.62% - -32.05% -23.95% -8.07% - -35.61%
Tax Burden Percent
113.53% 114.19% 113.09% - 117.14% 119.68% 46.50% - 112.80%
Interest Burden Percent
155.55% 130.90% 148.83% - 5,631.13% -1,001.71% -321.09% - 546.67%
Effective Tax Rate
0.00% 0.00% 0.00% - 0.00% 0.00% 0.00% - 0.00%
Return on Invested Capital (ROIC)
0.00% 0.00% 0.00% - 0.00% 0.00% 0.00% - -1.70%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% 0.00% 0.00% - 0.00% 0.00% 0.00% - -6.31%
Return on Net Nonoperating Assets (RNNOA)
0.00% 0.00% 0.00% - 0.00% 0.00% 0.00% - -22.35%
Return on Equity (ROE)
0.00% 0.00% 0.00% - 0.00% 0.00% 0.00% - -24.05%
Cash Return on Invested Capital (CROIC)
0.00% 0.00% 0.00% - 0.00% 0.00% 0.00% - -96.38%
Operating Return on Assets (OROA)
0.00% 0.00% 0.00% - 0.00% 0.00% 0.00% - -0.93%
Return on Assets (ROA)
0.00% 0.00% 0.00% - 0.00% 0.00% 0.00% - -5.73%
Return on Common Equity (ROCE)
0.00% 0.00% 0.00% - 0.00% 0.00% 0.00% - -20.47%
Return on Equity Simple (ROE_SIMPLE)
0.00% 0.00% 0.00% - 0.00% 0.00% 0.00% - 0.00%
Net Operating Profit after Tax (NOPAT)
12 54 82 79 -19 13 36 -63 -101
NOPAT Margin
6.25% 13.76% 14.04% - -1.96% 1.11% 2.66% - -4.85%
Net Nonoperating Expense Percent (NNEP)
0.00% 0.00% 0.00% - 9.54% 6.76% 2.66% - 4.61%
Return On Investment Capital (ROIC_SIMPLE)
- - - 1.05% -0.18% 0.10% 0.20% -0.25% -0.34%
Cost of Revenue to Revenue
31.39% 27.53% 24.51% - 26.73% 25.78% 27.03% - 34.46%
SG&A Expenses to Revenue
8.31% 5.50% 5.76% - 17.80% 14.36% 11.13% - 7.89%
R&D to Revenue
0.00% 0.00% 0.00% - 0.00% 0.00% 0.00% - 0.00%
Operating Expenses to Revenue
59.69% 52.81% 55.43% - 76.07% 72.64% 69.17% - 72.47%
Earnings before Interest and Taxes (EBIT)
-73 -216 -214 120 -4.77 24 74 -79 -120
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
14 -44 48 495 476 613 725 764 1,235
Valuation Ratios
- - - - - - - - -
Price to Book Value (P/BV)
0.00 0.00 0.00 - 4.85 29.85 17.57 - 8.58
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 - 4.91 48.42 23.92 - 11.89
Price to Revenue (P/Rev)
0.00 0.00 0.00 - 0.00 0.00 0.00 - 6.56
Price to Earnings (P/E)
0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00
Dividend Yield
0.00% 0.00% 0.00% - 0.00% 0.00% 0.00% - 0.00%
Earnings Yield
0.00% 0.00% 0.00% - 0.00% 0.00% 0.00% - 0.00%
Enterprise Value to Invested Capital (EV/IC)
0.00 0.00 0.00 - 1.86 7.01 5.35 - 2.38
Enterprise Value to Revenue (EV/Rev)
0.00 0.00 0.00 - 0.00 0.00 0.00 - 10.06
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 - 0.00 0.00 0.00 - 18.77
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00 - 0.00 0.00 0.00 - 10.47
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00
Leverage & Solvency
- - - - - - - - -
Debt to Equity
0.00 0.00 0.00 - 2.84 2.89 3.62 - 5.22
Long-Term Debt to Equity
0.00 0.00 0.00 - 1.61 1.94 2.66 - 3.64
Financial Leverage
0.00 0.00 0.00 - 2.02 2.36 2.84 - 3.54
Leverage Ratio
0.00 0.00 0.00 - 7.12 6.87 8.49 - 9.89
Compound Leverage Factor
0.00 0.00 0.00 - 401.07 -68.80 -27.25 - 54.07
Debt to Total Capital
0.00% 0.00% 0.00% - 73.95% 74.31% 78.35% - 83.93%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% - 32.06% 24.39% 20.72% - 25.48%
Long-Term Debt to Total Capital
0.00% 0.00% 0.00% - 41.89% 49.92% 57.63% - 58.45%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% - 0.00% 0.00% 0.00% - 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% - 9.87% 7.82% 0.00% - 0.00%
Common Equity to Total Capital
0.00% 0.00% 0.00% - 16.18% 17.87% 21.65% - 16.07%
Debt to EBITDA
0.00 0.00 0.00 - 0.00 0.00 0.00 - 7.45
Net Debt to EBITDA
0.00 0.00 0.00 - 0.00 0.00 0.00 - 6.54
Long-Term Debt to EBITDA
0.00 0.00 0.00 - 0.00 0.00 0.00 - 5.19
Debt to NOPAT
0.00 0.00 0.00 - 0.00 0.00 0.00 - -217.87
Net Debt to NOPAT
0.00 0.00 0.00 - 0.00 0.00 0.00 - -191.20
Long-Term Debt to NOPAT
0.00 0.00 0.00 - 0.00 0.00 0.00 - -151.73
Altman Z-Score
0.00 0.00 0.00 - -0.04 1.85 1.14 - 0.24
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% - 37.90% 30.44% 0.00% - 14.86%
Liquidity Ratios
- - - - - - - - -
Current Ratio
0.00 0.00 0.00 - 0.44 0.52 0.49 - 0.31
Quick Ratio
0.00 0.00 0.00 - 0.33 0.41 0.37 - 0.25
Cash Flow Metrics
- - - - - - - - -
Free Cash Flow to Firm (FCFF)
0.00 0.00 0.00 0.00 -9,282 -12,805 -14,861 -13,437 -17,114
Operating Cash Flow to CapEx
117.06% -5.24% 52.77% - 4.35% -10.24% 70.71% - 38.78%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00
Efficiency Ratios
- - - - - - - - -
Asset Turnover
0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.16
Accounts Receivable Turnover
0.00 0.00 0.00 - 0.00 0.00 0.00 - 3.92
Inventory Turnover
0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00
Fixed Asset Turnover
0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.25
Accounts Payable Turnover
0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.83
Days Sales Outstanding (DSO)
0.00 0.00 0.00 - 0.00 0.00 0.00 - 93.06
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00
Days Payable Outstanding (DPO)
0.00 0.00 0.00 - 0.00 0.00 0.00 - 441.47
Cash Conversion Cycle (CCC)
0.00 0.00 0.00 - 0.00 0.00 0.00 - -348.42
Capital & Investment Metrics
- - - - - - - - -
Invested Capital
0.00 0.00 0.00 7,170 9,263 12,819 14,897 20,544 26,276
Invested Capital Turnover
0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.35
Increase / (Decrease) in Invested Capital
0.00 0.00 0.00 0.00 9,263 12,819 14,897 13,374 17,013
Enterprise Value (EV)
0.00 0.00 0.00 - 17,218 89,845 79,632 - 62,643
Market Capitalization
1,500 1,500 1,500 - 9,244 79,344 68,136 - 40,827
Book Value per Share
$0.00 $0.00 $0.00 ($1.90) $7.76 $5.54 $7.94 $6.69 $9.05
Tangible Book Value per Share
$0.00 $0.00 $0.00 ($2.01) $7.66 $3.41 $5.83 $4.01 $6.53
Total Capital
0.00 0.00 0.00 9,234 11,781 14,872 17,913 24,708 29,618
Total Debt
0.00 0.00 0.00 7,926 8,712 11,052 14,035 21,373 24,859
Total Long-Term Debt
0.00 0.00 0.00 5,458 4,935 7,424 10,323 14,665 17,312
Net Debt
0.00 0.00 0.00 6,499 6,811 9,338 11,496 17,393 21,816
Capital Expenditures (CapEx)
1,742 2,247 1,215 3,498 1,407 2,453 2,389 4,060 7,695
Debt-free, Cash-free Net Working Capital (DFCFNWC)
0.00 0.00 0.00 -1,977 -2,152 -1,696 -3,810 -6,224 -7,705
Debt-free Net Working Capital (DFNWC)
0.00 0.00 0.00 -579 -252 17 -1,271 -2,244 -4,662
Net Working Capital (NWC)
0.00 0.00 0.00 -3,047 -4,028 -3,610 -4,984 -8,952 -12,209
Net Nonoperating Expense (NNE)
141 377 442 130 295 304 146 389 639
Net Nonoperating Obligations (NNO)
0.00 0.00 0.00 5,862 6,194 8,998 11,019 17,209 21,517
Total Depreciation and Amortization (D&A)
88 172 261 375 481 589 652 843 1,355
Debt-free, Cash-free Net Working Capital to Revenue
0.00% 0.00% 0.00% - 0.00% 0.00% 0.00% - -123.74%
Debt-free Net Working Capital to Revenue
0.00% 0.00% 0.00% - 0.00% 0.00% 0.00% - -74.87%
Net Working Capital to Revenue
0.00% 0.00% 0.00% - 0.00% 0.00% 0.00% - -196.07%
Earnings Adjustments
- - - - - - - - -
Adjusted Basic Earnings per Share
$0.00 $0.00 $0.00 ($0.24) ($1.40) ($0.60) ($0.22) ($0.53) ($1.40)
Adjusted Weighted Average Basic Shares Outstanding
0.00 0.00 0.00 218M 245.61M 486.59M 497.89M 435M 527M
Adjusted Diluted Earnings per Share
$0.00 $0.00 $0.00 ($0.24) ($1.49) ($0.60) ($0.22) ($0.50) ($1.40)
Adjusted Weighted Average Diluted Shares Outstanding
0.00 0.00 0.00 218M 249.29M 486.59M 497.89M 436M 527M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 0.00 0.00 0.00 479.98M 488.57M 498.32M 525.69M 545.57M
Normalized Net Operating Profit after Tax (NOPAT)
12 54 82 79 -19 13 36 -63 -101
Normalized NOPAT Margin
6.25% 13.76% 14.04% - -1.96% 1.11% 2.66% - -4.85%
Pre Tax Income Margin
-60.34% -71.55% -54.48% - -27.36% -20.01% -17.35% - -31.57%
Debt Service Ratios
- - - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00
NOPAT to Interest Expense
0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00
Payout Ratios
- - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% - 0.00% 0.00% 0.00% - -0.19%
Augmented Payout Ratio
0.00% 0.00% 0.00% - 0.00% 0.00% 0.00% - -0.19%

Financials Breakdown Chart

Key Financial Trends

CoreWeave’s latest quarter shows rapid growth, but profitability and balance-sheet leverage remain major concerns. In Q1 2026, revenue climbed to $2.08 billion, up sharply from $1.57 billion in Q4 2025 and $982 million in Q1 2025. However, the company still posted a net loss of $740 million, wider than the $452 million loss in the prior quarter and the $315 million loss a year ago.

Top-line momentum remains very strong. Revenue has scaled quickly over the last four quarters, moving from $188.7 million in Q1 2024 to $2.08 billion in Q1 2026. Gross profit also expanded to $1.36 billion in the latest quarter, showing the business can generate substantial revenue before heavy operating and financing costs.

Operating performance is improving, but losses persist. CoreWeave narrowed operating losses earlier in the growth cycle and even posted a small operating profit in Q3 2025, but Q1 2026 returned to a $144 million operating loss. The latest quarter was pressured by $1.27 billion in other operating expenses, which overwhelmed the strong gross profit.

Cash flow from operations is a bright spot. Q1 2026 operating cash flow was $2.98 billion, a major improvement from the $1.56 billion generated in Q4 2025 and far above the negative operating cash flow seen in parts of 2025. This suggests the core business is converting revenue into cash much better than the income statement implies.

Capital spending remains extremely heavy. CoreWeave spent $7.70 billion on property, plant, and equipment in Q1 2026, following $4.06 billion in Q4 2025 and $2.39 billion in Q3 2025. That level of investment supports growth, but it also means free cash flow remains under pressure.

The balance sheet carries significant debt. As of Q1 2026, total debt stood at about $24.9 billion, including $7.55 billion in short-term debt and $17.31 billion in long-term debt. That is a large obligation relative to the company’s $4.76 billion of common equity.

Liquidity improved, but liabilities still dominate the balance sheet. CoreWeave ended Q1 2026 with $2.24 billion in cash and equivalents, plus $777 million in restricted cash. However, total liabilities were $50.81 billion versus total assets of $55.57 billion, leaving a relatively thin equity cushion.

Shareholders have faced meaningful dilution. Weighted average basic shares outstanding rose from 246 million in Q1 2025 to 527 million in Q1 2026. The common stock balance also increased materially over the last year, which suggests equity issuance has been an important funding source.

Here are the most important takeaways for investors:

  • Revenue growth is exceptional and continued to accelerate in Q1 2026.
  • Gross profit remains very strong, showing the business can produce large-scale margin dollars.
  • Operating cash flow turned highly positive in the latest quarter at $2.98 billion.
  • Cash and restricted cash totaled over $3.0 billion, giving the company some near-term flexibility.
  • Balance-sheet expansion reflects aggressive infrastructure investment, which may support future revenue growth.
  • Accounts receivable remain large at $2.12 billion, so collections will matter.
  • Net loss widened to $740 million in Q1 2026.
  • Capex was enormous at $7.7 billion, keeping free cash flow under pressure.
  • Debt is very high at nearly $25 billion combined short- and long-term.
  • Share count has risen sharply, increasing dilution risk for existing investors.

Bottom line: CoreWeave is growing at a breakneck pace and is now generating very strong operating cash flow, but the company is still deeply loss-making, heavily levered, and spending aggressively to support expansion. For retail investors, this is a high-growth, high-risk story where execution and capital discipline will be critical.

06/16/26 10:28 PM ETAI Generated. May Contain Errors.

CoreWeave Financials - Frequently Asked Questions

According to the most recent income statement we have on file, CoreWeave's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

CoreWeave's net income appears to be on an upward trend, with a most recent value of -$1.17 billion in 2025, rising from -$594 million in 2023. The previous period was -$863 million in 2024. Find out what analysts predict for CoreWeave in the coming months.

CoreWeave's total operating income in 2025 was -$46 million, based on the following breakdown:
  • Total Gross Profit: $3.68 billion
  • Total Operating Expenses: $3.72 billion

Over the last 2 years, CoreWeave's total revenue changed from $229 million in 2023 to $5.13 billion in 2025, a change of 2,140.6%.

CoreWeave's total liabilities were at $45.97 billion at the end of 2025, a 178.2% increase from 2024, and a 178.2% increase since 2024.

In the past 1 years, CoreWeave's cash and equivalents has ranged from $1.36 billion in 2024 to $3.13 billion in 2025, and is currently $3.13 billion as of their latest financial filing in 2025.

Over the last 2 years, CoreWeave's book value per share changed from 0.00 in 2023 to 6.69 in 2025, a change of 669.3%.



Financial statements for NASDAQ:CRWV last updated on 5/12/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners